BRPI0714563B8 - métodos para detectar a pré-disposição à ou estágio de um câncer em um indivíduo mamífero, para triagem, identificação ou otimização de um medicamento anti-câncer, para modificação de um gene de mamífero in vitro e para avaliação da eficácia de um medicamento anti-câncer ou medicamento candidato - Google Patents
métodos para detectar a pré-disposição à ou estágio de um câncer em um indivíduo mamífero, para triagem, identificação ou otimização de um medicamento anti-câncer, para modificação de um gene de mamífero in vitro e para avaliação da eficácia de um medicamento anti-câncer ou medicamento candidatoInfo
- Publication number
- BRPI0714563B8 BRPI0714563B8 BRPI0714563A BRPI0714563A BRPI0714563B8 BR PI0714563 B8 BRPI0714563 B8 BR PI0714563B8 BR PI0714563 A BRPI0714563 A BR PI0714563A BR PI0714563 A BRPI0714563 A BR PI0714563A BR PI0714563 B8 BRPI0714563 B8 BR PI0714563B8
- Authority
- BR
- Brazil
- Prior art keywords
- cancer
- drug
- mammalian
- screening
- detecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Glass Compositions (AREA)
- Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06291176A EP1887088A1 (en) | 2006-07-20 | 2006-07-20 | Transcription infidelity, detection and uses thereof |
| EP06291176.3 | 2006-07-20 | ||
| PCT/EP2007/057541 WO2008009751A2 (en) | 2006-07-20 | 2007-07-20 | Transcription infidelity, detection and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0714563A2 BRPI0714563A2 (pt) | 2015-04-14 |
| BRPI0714563B1 BRPI0714563B1 (pt) | 2019-07-02 |
| BRPI0714563B8 true BRPI0714563B8 (pt) | 2021-05-25 |
Family
ID=37496681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0714563A BRPI0714563B8 (pt) | 2006-07-20 | 2007-07-20 | métodos para detectar a pré-disposição à ou estágio de um câncer em um indivíduo mamífero, para triagem, identificação ou otimização de um medicamento anti-câncer, para modificação de um gene de mamífero in vitro e para avaliação da eficácia de um medicamento anti-câncer ou medicamento candidato |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8288091B2 (enExample) |
| EP (3) | EP1887088A1 (enExample) |
| JP (1) | JP5298013B2 (enExample) |
| KR (1) | KR101502179B1 (enExample) |
| AT (1) | ATE524565T1 (enExample) |
| AU (1) | AU2007275068B2 (enExample) |
| BR (1) | BRPI0714563B8 (enExample) |
| CA (1) | CA2658305C (enExample) |
| CY (2) | CY1112125T1 (enExample) |
| DK (2) | DK2468885T3 (enExample) |
| ES (2) | ES2553435T3 (enExample) |
| HU (1) | HUE028135T2 (enExample) |
| IL (1) | IL196600A0 (enExample) |
| PL (2) | PL2468885T3 (enExample) |
| PT (2) | PT2468885E (enExample) |
| SI (2) | SI2468885T1 (enExample) |
| TR (1) | TR201112295Y (enExample) |
| WO (1) | WO2008009751A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2071334A1 (en) * | 2007-12-14 | 2009-06-17 | Transmedi SA | Compositions and methods of detecting TIABS |
| EP2080812A1 (en) | 2008-01-18 | 2009-07-22 | Transmedi SA | Compositions and methods of detecting post-stop peptides |
| EP2995688A1 (en) | 2014-09-12 | 2016-03-16 | Genclis | Methods of prognosing and treating triple negative breast cancer |
| WO2017100789A1 (en) * | 2015-12-11 | 2017-06-15 | Expression Pathology, Inc. | Srm/mrm assays |
| EP4148427A1 (en) | 2016-03-18 | 2023-03-15 | Genclis | Molecular origin of allergy |
| WO2018187216A1 (en) * | 2017-04-03 | 2018-10-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Expression cassettes and methods for detecting transcription errors |
| WO2019084158A1 (en) | 2017-10-26 | 2019-05-02 | Ultima Genomics, Inc. | METHODS AND SYSTEMS FOR SEQUENCE CALL |
| WO2020185790A1 (en) | 2019-03-10 | 2020-09-17 | Ultima Genomics, Inc. | Methods and systems for sequence calling |
| EP4010481A4 (en) | 2019-08-09 | 2023-09-20 | Nutcracker Therapeutics, Inc. | MICROFLUIDIC DEVICE AND METHODS OF USE |
| KR102334576B1 (ko) * | 2019-08-12 | 2021-12-07 | 한국생명공학연구원 | 융합 단백질 및 이를 포함하는 바이오 이미징용 조성물 |
| EP4211268A4 (en) * | 2020-09-10 | 2024-09-18 | Ultima Genomics, Inc. | SEQUENCE AND VARIANT CALLING METHODS AND SYSTEMS |
| WO2022108309A1 (ko) * | 2020-11-18 | 2022-05-27 | 한양대학교 에리카산학협력단 | 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법 |
| EP4162948A1 (en) | 2021-10-05 | 2023-04-12 | Genclis | Transcription infidelity derived chimeric immunogens and uses thereof |
| WO2023104904A2 (en) | 2021-12-08 | 2023-06-15 | Genclis | The sars-cov-2 and variants use two independent cell receptors to replicate |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4979330A (en) | 1989-10-10 | 1990-12-25 | Rorant Julius W | Suction insect trap device |
| US6120992A (en) | 1993-11-04 | 2000-09-19 | Valigene Corporation | Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human |
| AU2715601A (en) * | 1999-12-03 | 2001-06-12 | Koninklijke Nederlandse Akademie Van Wetenschappen | Clearance of aberrant protein in correlation with disease |
| WO2002077286A1 (en) | 2001-02-21 | 2002-10-03 | Gene Check, Inc. | Mutation detection using muts and reca |
| WO2006053061A2 (en) * | 2004-11-10 | 2006-05-18 | Kansas State University Research Foundation | Porcine reproductive and respiratory syndrome virus receptor components and uses thereof |
-
2006
- 2006-07-20 EP EP06291176A patent/EP1887088A1/en not_active Withdrawn
-
2007
- 2007-07-20 EP EP07787788A patent/EP2046986B1/en active Active
- 2007-07-20 PL PL11173357T patent/PL2468885T3/pl unknown
- 2007-07-20 KR KR1020097003423A patent/KR101502179B1/ko not_active Expired - Fee Related
- 2007-07-20 PL PL07787788T patent/PL2046986T3/pl unknown
- 2007-07-20 ES ES11173357.2T patent/ES2553435T3/es active Active
- 2007-07-20 HU HUE11173357A patent/HUE028135T2/en unknown
- 2007-07-20 PT PT111733572T patent/PT2468885E/pt unknown
- 2007-07-20 AU AU2007275068A patent/AU2007275068B2/en not_active Ceased
- 2007-07-20 ES ES07787788T patent/ES2373428T3/es active Active
- 2007-07-20 BR BRPI0714563A patent/BRPI0714563B8/pt not_active IP Right Cessation
- 2007-07-20 PT PT07787788T patent/PT2046986E/pt unknown
- 2007-07-20 WO PCT/EP2007/057541 patent/WO2008009751A2/en not_active Ceased
- 2007-07-20 CA CA2658305A patent/CA2658305C/en active Active
- 2007-07-20 JP JP2009519996A patent/JP5298013B2/ja not_active Expired - Fee Related
- 2007-07-20 SI SI200731705T patent/SI2468885T1/sl unknown
- 2007-07-20 US US12/374,431 patent/US8288091B2/en not_active Expired - Fee Related
- 2007-07-20 EP EP11173357.2A patent/EP2468885B1/en not_active Not-in-force
- 2007-07-20 DK DK11173357.2T patent/DK2468885T3/da active
- 2007-07-20 SI SI200730791T patent/SI2046986T1/sl unknown
- 2007-07-20 AT AT07787788T patent/ATE524565T1/de active
- 2007-07-20 DK DK07787788.4T patent/DK2046986T3/da active
- 2007-07-20 TR TR2011/12295U patent/TR201112295Y/tr unknown
-
2009
- 2009-01-19 IL IL196600A patent/IL196600A0/en active IP Right Grant
-
2011
- 2011-12-09 CY CY20111101225T patent/CY1112125T1/el unknown
-
2015
- 2015-11-17 CY CY20151101031T patent/CY1116939T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing | |
| Hogg et al. | Elevation of plasma tRNA fragments precedes seizures in human epilepsy | |
| Yokoyama et al. | DNA methylation alterations in Alzheimer’s disease | |
| ATE524565T1 (de) | Transkriptionsuntreue, nachweis und verwendungen davon | |
| Mondello et al. | CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders | |
| Carrard et al. | Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder | |
| Song et al. | Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson's disease patients | |
| US20160265057A1 (en) | Markers for amyotrophic lateral sclerosis (als) and presymptomatic alzheimer's disease (psad) | |
| Di Narzo et al. | A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide | |
| EP3190413B1 (en) | Method for predicting depression treatment drug alternatives | |
| BRPI0718322A2 (pt) | Métodos para diagnosticar uma suscetibilidade para câncer em um indivíduo humano, para identificar um marcador para o uso na avaliação da suscetibilidade para câncer, para genotipar uma amostra de ácido nucléico, para avaliar um inidivíduo quanto a probabilidade de resposta a um agente terapêutico, para predizer o prognóstico e para monitorar o progresso de um tratamento de um indivíduo, kit para avaliar a suscetibilidade para câncer em um indivíduo, uso de uma sonda de oligonucleotídeo, meio legível por computador, e, aparelho para determinar um indicador genético para câncer em um indivíduo. | |
| EA200801046A1 (ru) | Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro | |
| DK2038430T3 (da) | Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf | |
| Ruan et al. | Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: implication for the screening of cognitive frailty | |
| BRPI1008936B8 (pt) | método in vitro para detectar pré-disposição para ou diagnóstico e/ou prognóstico de fibrose hepática ou cirrose ocorrendo em um indivíduo humano | |
| Zhang et al. | A multi-scale approach to study biochemical and biophysical aspects of resveratrol on diesel exhaust particle-human primary lung cell interaction | |
| WO2009026153A1 (en) | Biomarkers for alzheimer's disease and methods using the same | |
| WO2009003706A3 (en) | Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones | |
| Dada et al. | Epigenetic studies in suicidal ideation and behavior | |
| Varani et al. | Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages | |
| Nunes et al. | Association of paraoxonase (PON) 1 activity, glutathione S-transferase GST T1/M1 and STin. 2 polymorphisms with comorbidity of tobacco use disorder and mood disorders | |
| Campisi et al. | Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life | |
| EP2539709A4 (en) | MORBUS ALZHEIMER SPECIFIC CHANGES OF PROTEIN KINASE C EPSILON (PKC EPSILON) PROTEIN MIRRORS | |
| WO2005118403A3 (en) | Methods for detecting gene expression in peripheral blood cells and uses thereof | |
| Tang et al. | Systematic Mendelian randomization of the human plasma proteome to identify therapeutic targets linking aging and frailty to perioperative delirium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/07/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2840 DE 10-06-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |